Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:06 AM
Ignite Modification Date:
2025-12-25 @ 2:06 AM
NCT ID:
NCT07126860
Eligibility Criteria:
Inclusion Criteria:
1. Participant must have a histologically diagnosed adenocarcinoma of the prostate
2. Participant has to be ≥ 18 years of age
3. Participant must have either localized, locally advanced, or metastatic PC which has been treated or is planned to be treated either by RP, EBRT, androgen deprivation therapy (ADT), androgen receptor signaling inhibitor (ARSI), or any combination
4. Participant must understand and remember the training regimen
5. Participant must have a smartphone to connect a wearable device
6. Participant must have a smartphone or computer to access the online platform
7. Participant has to be able to speak, understand, and read German or English
8. Participant must sign an informed consent form (ICF)
Exclusion Criteria:
1. Cardiovascular/neurological/musculoskeletal comorbidities with contraindications for resistance or aerobic training
2. High risk of pathological fracture due to unstable bone metastases (note: patients with bone metastasis are generally eligible for participation in the study and program as long as there is no acute high risk of fracture)
3. Any condition for which it may not be in the best interest of the patient to participate in the study
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
18 Years
Study:
NCT07126860
Study Brief:
Protocol Section:
NCT07126860